The impact of midodrine on patients with heart failure with reduced ejection fraction- retrospective cohort study

1 September 2025 (15:15 - 16:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Jamal Mahar

Banner University Medical Center Phoenix, Phoenix (United States of America)

6 More presentations in this session

Presentation thumbnail

Stimulation in home based cardiac rehabilitation protocol, the effect on aerobic capacity and quality of life

Assistant Professor R. Kallel (Gabes, TN)

Abstract Slides

Presentation thumbnail

Survival impact of amiodarone therapy in heart failure: insights from the Icelandic Heart Failure registry

Doctor P. Gudjonsson (Reykjavik, IS)

Abstract Slides

Presentation thumbnail

Efficacy and safety of GLP-1 agonists in obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized placebo-controlled trials.

Miss J. Khater (Beirut, LB)

Abstract Slides

Presentation thumbnail

Efficacy of intravenous and oral iron replacement therapies in heart failure: a network meta-analysis

Mr R. Mizori (London, GB)

Abstract Slides

Presentation thumbnail

Efficacy of liposomal bivalent stabilized iron sulfate in improving iron deficiency and quality of life in patients with chronic heart failure: lower costs for better therapy?

Doctor E. Tagliamonte (Nocera Inferiore, IT)

Abstract Slides

Access the full session

Session thumbnail

Managing comorbidities in heart failure

The Event

Event poster

ESC Congress 2025

1 September 2025 15:15 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources